Interstitial pneumonia in a patient treated with TAS-102 for metastatic colorectal cancer: a case report

TAS-102, a new treatment option for patients with metastatic colorectal cancer that is refractory or intolerant to standard therapies, has been improving survival with acceptable tolerability and adverse event...

http://ift.tt/2fhQPZa